X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18331) 18331
Book Chapter (917) 917
Newsletter (222) 222
Magazine Article (53) 53
Book / eBook (29) 29
Dissertation (19) 19
Web Resource (6) 6
Conference Proceeding (5) 5
Book Review (3) 3
Publication (3) 3
Newspaper Article (2) 2
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15468) 15468
science & technology (10092) 10092
life sciences & biomedicine (9859) 9859
female (9831) 9831
male (8928) 8928
middle aged (7485) 7485
adult (7039) 7039
aged (5236) 5236
adenoma - surgery (3637) 3637
adenoma (3443) 3443
adenoma - pathology (3178) 3178
surgery (2897) 2897
abridged index medicus (2575) 2575
tumors (2560) 2560
endocrinology & metabolism (2433) 2433
adenoma - diagnosis (2149) 2149
adenoma - complications (2135) 2135
adolescent (2046) 2046
oncology (2022) 2022
pituitary neoplasms - surgery (1991) 1991
medicine & public health (1956) 1956
treatment outcome (1857) 1857
retrospective studies (1838) 1838
pituitary adenoma (1707) 1707
aged, 80 and over (1539) 1539
follow-up studies (1491) 1491
magnetic resonance imaging (1435) 1435
adenoma - drug therapy (1405) 1405
diagnosis, differential (1358) 1358
adenoma - metabolism (1340) 1340
pituitary neoplasms - pathology (1290) 1290
animals (1256) 1256
pituitary neoplasms - complications (1256) 1256
cancer (1240) 1240
neurosciences & neurology (1168) 1168
gastroenterology & hepatology (1167) 1167
adenoma - therapy (1149) 1149
colorectal cancer (1138) 1138
pathology (1132) 1132
child (1074) 1074
prognosis (1059) 1059
immunohistochemistry (1057) 1057
pituitary neoplasms - drug therapy (1032) 1032
clinical neurology (1024) 1024
pituitary neoplasms - diagnosis (999) 999
care and treatment (978) 978
risk factors (973) 973
diagnosis (942) 942
pituitary (940) 940
adenoma - genetics (939) 939
research (921) 921
tomography, x-ray computed (894) 894
young adult (875) 875
pituitary neoplasms - metabolism (822) 822
adenoma - diagnostic imaging (795) 795
analysis (765) 765
acromegaly (763) 763
patients (751) 751
time factors (751) 751
pituitary neoplasms - therapy (726) 726
combined modality therapy (724) 724
adenoma - radiotherapy (697) 697
health aspects (685) 685
pituitary neoplasms - radiotherapy (659) 659
diabetes (649) 649
colonoscopy (646) 646
radiotherapy (642) 642
pregnancy (627) 627
general & internal medicine (626) 626
medicine, general & internal (622) 622
endocrinology (621) 621
adenoma - secretion (614) 614
pituitary neoplasms - secretion (583) 583
adenoma - blood (570) 570
neurosurgery (569) 569
bromocriptine - therapeutic use (565) 565
colorectal neoplasms - pathology (558) 558
mutation (549) 549
endoscopy (546) 546
pituitary gland tumors (545) 545
mice (541) 541
medicine (531) 531
internal medicine (522) 522
adenocarcinoma - pathology (501) 501
pituitary gland (490) 490
adenoma - epidemiology (477) 477
radiology, nuclear medicine & medical imaging (475) 475
genetic aspects (473) 473
prospective studies (468) 468
carcinoma (453) 453
gastroenterology (450) 450
gene expression (450) 450
biopsy (442) 442
neoplasm staging (441) 441
octreotide - therapeutic use (438) 438
prolactin - blood (437) 437
research article (423) 423
parathyroid neoplasms - surgery (418) 418
acromegaly - etiology (416) 416
adrenalectomy (414) 414
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17510) 17510
German (691) 691
French (543) 543
Japanese (407) 407
Spanish (194) 194
Russian (181) 181
Italian (158) 158
Polish (84) 84
Portuguese (79) 79
Chinese (65) 65
Czech (40) 40
Korean (34) 34
Hungarian (31) 31
Dutch (28) 28
Danish (23) 23
Hebrew (14) 14
Norwegian (14) 14
Turkish (10) 10
Croatian (7) 7
Romanian (6) 6
Slovak (6) 6
Finnish (5) 5
Arabic (4) 4
Lithuanian (4) 4
Swedish (4) 4
Serbian (3) 3
Bulgarian (2) 2
Afrikaans (1) 1
Greek (1) 1
Icelandic (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 03/2018, Volume 378, Issue 12, pp. 1085 - 1095
Among patients with endoscopically resected early gastric cancers who were infected with Helicobacter pylori , the incidence of metachronous gastric cancer was... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Adenoma - surgery | Prospective Studies | Follow-Up Studies | Rabeprazole - therapeutic use | Humans | Middle Aged | Helicobacter Infections - complications | Male | Neoplasm Recurrence, Local - etiology | Incidence | Anti-Bacterial Agents - therapeutic use | Helicobacter pylori | Helicobacter Infections - drug therapy | Adult | Female | Gastritis, Atrophic - etiology | Stomach Neoplasms - epidemiology | Drug Therapy, Combination | Stomach Neoplasms - etiology | Stomach - pathology | Double-Blind Method | Neoplasm Recurrence, Local - prevention & control | Kaplan-Meier Estimate | Clarithromycin - therapeutic use | Gastroscopy | Proton Pump Inhibitors - therapeutic use | Stomach Neoplasms - prevention & control | Amoxicillin - therapeutic use | Intention to Treat Analysis | Aged | Neoplasm Recurrence, Local - epidemiology | Stomach Neoplasms - surgery | Prevention | Treatment outcome | Usage | Patient outcomes | Analysis | Proton pump inhibitors | Stomach cancer | Bacterial infections | Enrollments | Gastric mucosa | Systematic review | Infections | Adenoma | Metastasis | Patients | Evidence-based medicine | Meta-analysis | Atrophy | Motivation | Antibiotics | Biopsy | Classification | Endoscopy | Gastric cancer | Long-term effects | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Endocrine-related cancer, ISSN 1479-6821, 12/2015, Volume 22, Issue 6, pp. 877 - 887
Effective adverse event (AE) management is critical to maintaining patients on anticancer therapies... 
Adverse events | Targeted therapy | Tyrosine kinase inhibitor | Sorafenib | Differentiated thyroid cancer | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Adenoma, Oxyphilic - enzymology | Dyspnea - chemically induced | Thyroid Neoplasms - enzymology | Prevalence | Adenocarcinoma, Follicular - radiotherapy | Humans | Middle Aged | Drug Resistance, Neoplasm | Hypertension - drug therapy | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Protein Kinase Inhibitors - adverse effects | Weight Loss - drug effects | Incidence | Neoplasms, Second Primary - chemically induced | Adenocarcinoma, Follicular - drug therapy | Adenoma, Oxyphilic - drug therapy | Hypocalcemia - epidemiology | Niacinamide - adverse effects | Carcinoma, Papillary - drug therapy | Niacinamide - therapeutic use | Thyroid Neoplasms - radiotherapy | Adenocarcinoma, Follicular - enzymology | Neoplasms, Second Primary - epidemiology | Niacinamide - analogs & derivatives | Diarrhea - epidemiology | Diarrhea - chemically induced | Iodine Radioisotopes - therapeutic use | Hypocalcemia - chemically induced | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Hypertension - chemically induced | Female | Carcinoma, Papillary - enzymology | Hypertension - epidemiology | Adenoma, Oxyphilic - radiotherapy | Drug Eruptions - etiology | Phenylurea Compounds - therapeutic use | Dyspnea - epidemiology | Disease-Free Survival | Carcinoma, Papillary - radiotherapy | Fatigue - epidemiology | Thyroid Neoplasms - drug therapy | Protein Kinase Inhibitors - therapeutic use | Aged | Diarrhea - drug therapy | Drug Eruptions - epidemiology | Radiopharmaceuticals - therapeutic use | Index Medicus | targeted therapy | Research | tyrosine kinase inhibitor | adverse events | sorafenib | differentiated thyroid cancer
Journal Article
European journal of endocrinology, ISSN 0804-4643, 06/2017, Volume 176, Issue 6, pp. 769 - 777
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide (TMZ) in pituitary tumors (PT), all around 50%. However, the... 
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | ACTH-Secreting Pituitary Adenoma - drug therapy | ACTH-Secreting Pituitary Adenoma - prevention & control | Follow-Up Studies | Dacarbazine - therapeutic use | Tumor Burden - radiation effects | Humans | Drug Resistance, Neoplasm | Male | Practice Patterns, Physicians | Chemoradiotherapy | Prolactinoma - prevention & control | Prolactinoma - radiotherapy | Neoplasm Recurrence, Local - pathology | Neoplasm Grading | Dacarbazine - analogs & derivatives | Adult | Female | Pituitary Neoplasms - radiotherapy | Retrospective Studies | Carcinoma - pathology | France | Prolactinoma - drug therapy | Pituitary Neoplasms - prevention & control | Prolactinoma - pathology | ACTH-Secreting Pituitary Adenoma - radiotherapy | Carcinoma - drug therapy | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Carcinoma - prevention & control | Pituitary Neoplasms - pathology | Carcinoma - radiotherapy | Antineoplastic Agents, Alkylating - therapeutic use | Pituitary Neoplasms - drug therapy | Tumor Burden - drug effects | Survival Analysis | Neoplasm Recurrence, Local - epidemiology | Temozolomide | ACTH-Secreting Pituitary Adenoma - pathology | Cohort Studies | Carcinoma | Brain tumors | Pituitary | Standardization | Radiation therapy | Survival | Patients | Tumors
Journal Article